164 related articles for article (PubMed ID: 22469754)
1. Effects of palmitoylethanolamide on intestinal injury and inflammation caused by ischemia-reperfusion in mice.
Di Paola R; Impellizzeri D; Torre A; Mazzon E; Cappellani A; Faggio C; Esposito E; Trischitta F; Cuzzocrea S
J Leukoc Biol; 2012 Jun; 91(6):911-20. PubMed ID: 22469754
[TBL] [Abstract][Full Text] [Related]
2. Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice.
Di Paola R; Impellizzeri D; Mondello P; Velardi E; Aloisi C; Cappellani A; Esposito E; Cuzzocrea S
Shock; 2012 Oct; 38(4):356-66. PubMed ID: 22772472
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of apocynin, an inhibitor of NADPH oxidase activity, in splanchnic artery occlusion and reperfusion.
Paterniti I; Galuppo M; Mazzon E; Impellizzeri D; Esposito E; Bramanti P; Cuzzocrea S
J Leukoc Biol; 2010 Nov; 88(5):993-1003. PubMed ID: 20807703
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid-induced TNF receptor family gene (GITR) knockout mice exhibit a resistance to splanchnic artery occlusion (SAO) shock.
Cuzzocrea S; Nocentini G; Di Paola R; Mazzon E; Ronchetti S; Genovese T; Muià C; Caputi AP; Riccardi C
J Leukoc Biol; 2004 Nov; 76(5):933-40. PubMed ID: 15316036
[TBL] [Abstract][Full Text] [Related]
5. Protective Effects of Ultramicronized Palmitoylethanolamide (PEA-um) in Myocardial Ischaemia and Reperfusion Injury in VIVO.
Di Paola R; Cordaro M; Crupi R; Siracusa R; Campolo M; Bruschetta G; Fusco R; Pugliatti P; Esposito E; Cuzzocrea S
Shock; 2016 Aug; 46(2):202-13. PubMed ID: 26844976
[TBL] [Abstract][Full Text] [Related]
6. Splanchnic ischemia and reperfusion injury is reduced by genetic or pharmacological inhibition of TNF-alpha.
Esposito E; Mazzon E; Muià C; Meli R; Sessa E; Cuzzocrea S
J Leukoc Biol; 2007 Apr; 81(4):1032-43. PubMed ID: 17210619
[TBL] [Abstract][Full Text] [Related]
7. Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-alpha agonist, modulates carrageenan-induced paw edema in mice.
D'Agostino G; La Rana G; Russo R; Sasso O; Iacono A; Esposito E; Raso GM; Cuzzocrea S; Lo Verme J; Piomelli D; Meli R; Calignano A
J Pharmacol Exp Ther; 2007 Sep; 322(3):1137-43. PubMed ID: 17565008
[TBL] [Abstract][Full Text] [Related]
8. Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia.
D'Agostino G; La Rana G; Russo R; Sasso O; Iacono A; Esposito E; Mattace Raso G; Cuzzocrea S; Loverme J; Piomelli D; Meli R; Calignano A
Eur J Pharmacol; 2009 Jun; 613(1-3):54-9. PubMed ID: 19386271
[TBL] [Abstract][Full Text] [Related]
9. PARG activity mediates intestinal injury induced by splanchnic artery occlusion and reperfusion.
Cuzzocrea S; Di Paola R; Mazzon E; Cortes U; Genovese T; Muià C; Li W; Xu W; Li JH; Zhang J; Wang ZQ
FASEB J; 2005 Apr; 19(6):558-66. PubMed ID: 15791006
[TBL] [Abstract][Full Text] [Related]
10. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide.
Lo Verme J; Fu J; Astarita G; La Rana G; Russo R; Calignano A; Piomelli D
Mol Pharmacol; 2005 Jan; 67(1):15-9. PubMed ID: 15465922
[TBL] [Abstract][Full Text] [Related]
11. Effects of a polyphenol present in olive oil, oleuropein aglycone, in a murine model of intestinal ischemia/reperfusion injury.
Campolo M; Di Paola R; Impellizzeri D; Crupi R; Morittu VM; Procopio A; Perri E; Britti D; Peli A; Esposito E; Cuzzocrea S
J Leukoc Biol; 2013 Feb; 93(2):277-87. PubMed ID: 23233730
[TBL] [Abstract][Full Text] [Related]
12. Adenosine A2A receptor-selective stimulation reduces signaling pathways involved in the development of intestine ischemia and reperfusion injury.
Di Paola R; Melani A; Esposito E; Mazzon E; Paterniti I; Bramanti P; Pedata F; Cuzzocrea S
Shock; 2010 May; 33(5):541-51. PubMed ID: 19924030
[TBL] [Abstract][Full Text] [Related]
13. Liver X receptor agonist treatment reduced splanchnic ischemia and reperfusion injury.
Crisafulli C; Di Paola R; Mazzon E; Paterniti I; Galuppo M; Genovese T; Bramanti P; Cappellani A; Cuzzocrea S
J Leukoc Biol; 2010 Feb; 87(2):309-21. PubMed ID: 20028773
[TBL] [Abstract][Full Text] [Related]
14. Olprinone, a PDE3 inhibitor, modulates the inflammation associated with myocardial ischemia-reperfusion injury in rats.
Di Paola R; Mazzon E; Paterniti I; Impellizzeri D; Bramanti P; Cuzzocrea S
Eur J Pharmacol; 2011 Jan; 650(2-3):612-20. PubMed ID: 21035441
[TBL] [Abstract][Full Text] [Related]
15. WY 14643, a potent exogenous PPAR-alpha ligand, reduces intestinal injury associated with splanchnic artery occlusion shock.
Cuzzocrea S; Di Paola R; Mazzon E; Genovese T; Muià C; Caputi AP
Shock; 2004 Oct; 22(4):340-6. PubMed ID: 15377889
[TBL] [Abstract][Full Text] [Related]
16. Heparin-binding EGF-like growth factor downregulates expression of adhesion molecules and infiltration of inflammatory cells after intestinal ischemia/reperfusion injury.
Xia G; Martin AE; Besner GE
J Pediatr Surg; 2003 Mar; 38(3):434-9. PubMed ID: 12632363
[TBL] [Abstract][Full Text] [Related]
17. Prostacyclin-induced peroxisome proliferator-activated receptor-alpha translocation attenuates NF-kappaB and TNF-alpha activation after renal ischemia-reperfusion injury.
Chen HH; Chen TW; Lin H
Am J Physiol Renal Physiol; 2009 Oct; 297(4):F1109-18. PubMed ID: 19640904
[TBL] [Abstract][Full Text] [Related]
18. Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion.
Patel NS; Chatterjee PK; Di Paola R; Mazzon E; Britti D; De Sarro A; Cuzzocrea S; Thiemermann C
J Pharmacol Exp Ther; 2005 Mar; 312(3):1170-8. PubMed ID: 15572648
[TBL] [Abstract][Full Text] [Related]
19. TLR4 mediates lung injury and inflammation in intestinal ischemia-reperfusion.
Ben DF; Yu XY; Ji GY; Zheng DY; Lv KY; Ma B; Xia ZF
J Surg Res; 2012 May; 174(2):326-33. PubMed ID: 21392794
[TBL] [Abstract][Full Text] [Related]
20. Propionate reduces the cytokine-induced VCAM-1 and ICAM-1 expression by inhibiting nuclear factor-kappa B (NF-kappaB) activation.
Zapolska-Downar D; Naruszewicz M
J Physiol Pharmacol; 2009 Jun; 60(2):123-31. PubMed ID: 19617655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
